By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Topical steroids > Dermasilkrx sds pak > Triamcinolone Topical Dosage
Topical steroids
https://themeditary.com/dosage-information/triamcinolone-topical-dosage-10162.html

Triamcinolone Topical Dosage

Drug Detail:Dermasilkrx sds pak (Triamcinolone topical [ trye-am-sin-oh-lone ])

Drug Class: Topical steroids

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Dermatitis

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:

  • Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
  • If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Eczema

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:

  • Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
  • If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Psoriasis

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:

  • Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
  • If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Stomatitis

Paste: Press a small dab (about 1/4 inch) to the lesion until a thin film develops.

Comments:

  • The paste should be applied at bedtime to permit steroid contact with the lesion throughout the night.
  • It may be necessary to apply the paste two or three times a day, depending on the severity of symptoms.
  • If regeneration has not occurred in seven days, additional investigation is recommended.

Use: Temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma

Usual Pediatric Dose for Dermatitis

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:

  • Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
  • If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Eczema

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:

  • Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
  • If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Psoriasis

Cream/ointment: Apply a thin film to affected areas two to four times a day
Lotion: Apply a thin film to affected areas three to four times a day
Spray: Three to four applications a day

Comments:

  • Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
  • If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Stomatitis

Paste: Press a small dab (about 1/4 inch) to the lesion until a thin film develops.

Comments:

  • The paste should be applied at bedtime to permit steroid contact with the lesion throughout the night.
  • It may be necessary to apply the paste two or three times a day, depending on the severity of symptoms.
  • If regeneration has not occurred in seven days, additional investigation is recommended.

Use: Temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced HPA axis suppression and Cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • This drug should not be used on the face, groin, or axillae, unless directed by a healthcare professional.
  • The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
  • Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.
  • Long term therapy in infants should be avoided as adrenal suppression may occur.
  • Patients on long term therapy should not be given any live attenuated vaccines if there is a risk of immunosuppression.

Storage requirements:
  • Avoid freezing
Lotion: Shake well before using
Spray: Avoid excessive heat; do not puncture or incinerate

Monitoring:
  • Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
  • Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.
  • This medication is to be used as directed by the physician. It is for external use only. Contact with the eyes should be avoided.
  • Patients should be advised not to use this medication for any condition other than for which it was prescribed.
Share this Article
Latest News
Medical News

Obesity, unhealthy lifestyles may cause heart to age by 5–45 years

May 08, 2025
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Heart disease: Just 3 minutes of 'incidental activity' may lower...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by